Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001949864-24-000003
Filing Date
2024-03-08
Accepted
2024-03-08 13:56:10
Documents
33
Period of Report
2024-01-31

Document Format Files

Seq Description Document Type Size
1 magna10q31jan2024.htm   iXBRL 10-Q 289994
2 ex31.htm EX-31.1 10428
3 ex32.htm EX-32.1 5661
  Complete submission text file 0001949864-24-000003.txt   1374650

Data Files

Seq Description Document Type Size
4 none-20240131_cal.xml EX-101.CAL 13378
5 none-20240131_def.xml EX-101.DEF 12626
6 none-20240131_lab.xml EX-101.LAB 102731
7 none-20240131_pre.xml EX-101.PRE 71238
8 none-20240131.xsd EX-101.SCH 9778
34 EXTRACTED XBRL INSTANCE DOCUMENT magna10q31jan2024_htm.xml XML 94151
Mailing Address 325 W WASHINGTON ST, STE 2877 SAN DIEGO CA 92103
Business Address 325 W WASHINGTON ST, STE 2877 SAN DIEGO CA 92103 16204692043
Mag Magna Corp. (Filer) CIK: 0001949864 (see all company filings)

EIN.: 981626237 | State of Incorp.: WY | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 333-268561 | Film No.: 24733608
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)